Technology will not replace HDI or SonosPhilips is preparing a new technology platform upon which to base future ultrasound systems. Dubbed the Boris Platform, it is not a physical system but rather a fundamental architecture that
Technology will not replace HDI or Sonos
Philips is preparing a new technology platform upon which to base future ultrasound systems. Dubbed the Boris Platform, it is not a physical system but rather a fundamental architecture that can be used to support other systems and features in the future, according to Terrence J. Sweeney, Philips vice president of corporate quality and regulatory affairs.
"We are developing capabilities-the hardware, software interfaces-not a new product, like something you would wheel down a hallway," he said. "It will evolve into products later on."
Boris will not replace either of Philips' current major product platforms, the radiology-oriented HDI or cardiology-oriented Sonos. Boris simply gives Philips an additional technology with which to advance the state of the art, according to Sweeney.
R&D engineers with a penchant for Saturday morning cartoons (e.g., moose and squirrel) apparently named the technology platform, which cleared the FDA in March (SCAN 5/14/03). Its development and the decision to submit it to the FDA were not so frivolous. The 510(k) submission, according to Sweeney, is intended to establish a technical file to which FDA reviewers can refer when evaluating future filings regarding this architecture.
"Due to the innovative nature of the Boris technology, we started working early with the FDA to assure their medical device review requirements could be met," he said. "By obtaining this first clearance, a regulatory pathway has now been established supporting the development of new ultrasound applications."
If all goes according to plan, this will have been the first of many Boris submissions, Sweeney said, with each new one offering an expanded capability.
"We plan to use this as a 510(k) platform from which to launch things," he said. "It's designed to help us get things cleared more rapidly."
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.